Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9626
PUT
iShares US Oil Equipment & Services ETF
IEZ
$393M
| $193K | ﹤0.01% |
17,200
+2,000
| +13% | +$18.6K |
|
9627
LiveOne
LVO
$57.2M
| $193K | ﹤0.01% |
5,898
+3,403
| +136% | +$82.9K |
|
9628
SandRidge Energy
SD
$520M
| $193K | ﹤0.01% |
+62,270
| New | +$153K |
|
|
OSG
9629
PUT
Octave Specialty Group
OSG
$221M
| $192K | ﹤0.01% |
+12,500
| New | +$184K |
|
9630
PUT
Golub Capital BDC
GBDC
$3.44B
| $192K | ﹤0.01% |
+13,600
| New | +$186K |
|
|
PDM
9631
PUT
Piedmont Realty Trust
PDM
$1.19B
| $192K | ﹤0.01% |
+11,800
| New | +$174K |
|
9632
CALL
Pebblebrook Hotel Trust
PEB
$2.06B
| $192K | ﹤0.01% |
+10,200
| New | +$165K |
|
9633
Precigen
PGEN
$2.18B
| $192K | ﹤0.01% |
18,779
-290,423
| -94% | -$1.88M |
|
9634
ProShares Trust UltraShort Lehman 7-10 Year Treasury
PST
$10.6M
| $192K | ﹤0.01% |
12,428
+804
| +7% | +$12.4K |
|
|
AVEO
9635
PUT
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $192K | ﹤0.01% |
33,260
+5,460
| +20% | +$31.3K |
|
|
YDKG
9636
CALL
Yueda Digital Holding
YDKG
$5.92M
| $191K | ﹤0.01% |
+219
| New | +$102K |
|
9637
iShares MSCI Poland ETF
EPOL
$822M
| $191K | ﹤0.01% |
+10,055
| New | +$174K |
|
9638
PUT
Vera Bradley
VRA
$93M
| $191K | ﹤0.01% |
24,000
+5,500
| +30% | +$41.6K |
|
9639
CALL
Cato Corp
CATO
$67.9M
| $190K | ﹤0.01% |
19,800
+1,800
| +10% | +$14.2K |
|
|
9640
Cato Corp
CATO
$67.9M
| $190K | ﹤0.01% |
19,758
+5,150
| +35% | +$40.6K |
|
9641
CALL
Precision BioSciences
DTIL
$205M
| $190K | ﹤0.01% |
760
-140
| -16% | -$34.3K |
|
9642
Mizuho Financial
MFG
$132B
| $190K | ﹤0.01% |
+74,335
| New | +$192K |
|
9643
PUT
Prospect Capital
PSEC
$1.15B
| $190K | ﹤0.01% |
35,200
-25,400
| -42% | -$134K |
|
|
EXPR
9644
CALL
DELISTED
Express, Inc.
EXPR
| $190K | ﹤0.01% |
10,435
+8,675
| +493% | +$164K |
|
|
SIOX
9645
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $190K | ﹤0.01% |
68,431
+5,987
| +10% | +$17.4K |
|
9646
America Movil
AMX
$70.3B
| $189K | ﹤0.01% |
13,028
+2,875
| +28% | +$39K |
|
|
DX
9647
CALL
Dynex Capital
DX
$3.24B
| $189K | ﹤0.01% |
10,600
-16,100
| -60% | -$275K |
|
|
SFT
9648
CALL
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $189K | ﹤0.01% |
2,280
+760
| +50% | +$70.4K |
|
9649
American Coastal Insurance
ACIC
$466M
| $188K | ﹤0.01% |
32,820
-12,691
| -28% | -$64.1K |
|
9650
AXT Inc
AXTI
$5.34B
| $188K | ﹤0.01% |
+19,646
| New | +$158K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.